| Financial Year |
March 31 2023 |
| Monetary Funds |
225,812,000,000.00 |
| Held-for-trading Financial Assets |
107,160,000,000.00 |
| Notes Receivable |
1,208,000,000.00 |
| Accounts Receivable |
69,719,000,000.00 |
| Advances to Suppliers |
9,609,000,000.00 |
| Other Receivables |
39,950,000,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,146,000,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,995,000,000.00 |
| Total Current Assets |
498,647,000,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
178,994,000,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
690,681,000,000.00 |
| Under-construction Projects |
88,613,000,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,448,000,000.00 |
| R&D expenses |
1,390,000,000.00 |
| Goodwill |
1,000,000.00 |
| Long-Term Deferred and Prepaid Expenses |
5,238,000,000.00 |
| Deferred Income Tax Assets |
44,922,000,000.00 |
| Other Non-Current Assets |
77,216,000,000.00 |
| Sub-Total of Non-Current Assets |
1,458,910,000,000.00 |
| Total Assets |
1,957,557,000,000.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,752,000,000.00 |
| Accounts Payable |
291,048,000,000.00 |
| Accounts Received In Advance |
77,480,000,000.00 |
| Employee Compensation Payable |
15,761,000,000.00 |
| Taxes Payable |
11,140,000,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,903,000,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,677,000,000.00 |
| Other Current Liabilities |
1,725,000,000.00 |
| Sub-Total of Current Liabilities |
560,401,000,000.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,979,000,000.00 |
| Other Non-Current Liabilities |
1,639,000,000.00 |
| Sub-Total of Non-Current Liabilities |
103,235,000,000.00 |
| Total Liabilities |
663,636,000,000.00 |
| Paid-In Capital(Or Share Stock) |
453,760,000,000.00 |
| Capital Surplus |
-302,271,000,000.00 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,135,187,000,000.00 |
| Minority Stockholder's Interest |
4,091,000,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,289,830,000,000.00 |
| Owner's Equity（Stockholder's Equity） |
1,293,921,000,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,957,557,000,000.00 |
